Due to unforeseen circumstances, Klaus Hochleitner is unable to host this webinar as originally planned. Thanks to Dominik de Cassan for covering the session. Quantitative tests require a much more ...

In our best practices blog, we explore how lateral flow assay design affects test performance. Read on to gain a deeper understanding of the development process, enabling you to streamline the ...

SYGNIS AG announced the launch of its Universal Lateral Flow Assay (LFA) kit, the latest addition to its expanding range of lateral flow assay products and services which are being commercialized ...

Lateral Flow Assays Market, By Product Type (Kits & Reagents and Lateral Flow Readers), By Technique (Sandwich Assays, Competitive Assays, and Multiplex Detection Assays), By Application (Clinical ...

SYGNIS AG today announced the launch of its Universal Lateral Flow Assay (LFA) kit, the latest addition to its expanding range of lateral flow assay products and services which are being ...

Market Size – USD 340.7 Million in 2021, Market Growth – at a CAGR of 4.1%, Market Trends – Growing interest for Point-of-Care (PoC) settings VANCOUVER, BRITISH COLUMBIA, CANADA, May 4, 2023 ...

In this interview, News-Medical talks to Andre Alfaro from nanoComposix (now a Fortis Life Sciences Company) about the possibilities lateral flow assays offer in both the present and potential ...

BioPorto Diagnostics and Qiagen have validated BioPorto’s generic Rapid Assay Device (gRAD) lateral flow platform on Qiagen’s ESEQuant LR3 Lateral Flow System. The firms said combining gRAD with the ...

DUBLIN, Feb. 25, 2021 /PRNewswire/ -- The "Lateral Flow Assays Market by Application (Clinical Testing (Pregnancy, Infectious Diseases (Mosquito, Influenza, STI, Hepatitis, TB) Cardiac Marker Lipid ...

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications ...

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...